Nabriva Therapeutics plc (NBRV) — Analyst outlook / Analyst consensus target is. Based on 10 analyst ratings, the consensus is bullish — 4 Buy, 5 Hold, 1 Sell.
The consensus price target is $1.00, representing a downside of 29.6% from the current price $1.42.
NBRV Stock — 12-Month Price Forecast
$1.00
▼ -29.58% Downside
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for Nabriva Therapeutics plc, the price target is $1.00.
The average price target represents a -29.58% change from the last price of $1.42.
NBRV Analyst Ratings
Hold
Based on 10 analysts giving stock ratings to Nabriva Therapeutics plc in the past 3 months
